Regular teeth brushing and proper oral care can play a big role in the fight against COVID-19, as patients with coronavirus infection are nine times more likely to die if they have gum disease, according to a new study. Study,…

A report from The New York Times said that the treatment of Donald Trump for the coronavirus could cost the American health care system more than $ 100. The most important of the NYT report compiled by the Independent. According to the newspaper's calculations, the president's helicopter flights, multiple tests ...

The United States was distrustful of the Russian coronavirus vaccine and refused to cooperate, according to CNN television. The Ministry of Health states that it did not offer such cooperation to the Americans. This and other news is in the BBC review. Do Americans need a Russian vaccine? CNN reports...

After a three-month hospitalization with COVID-19, during which he suffered a heart attack and stroke, 61-year-old Hector Reynoso was discharged from La Jolla Hospital in San Diego on July 24, writes NBC San Diego. “Three long months in the hospital with sadness and uncertainty,” said...

For most people, coronavirus is a threat. But it appears to be a business opportunity for some chiropractors in the US, reports the LA Times. The California Board of Chiropractic Examiners, the state's regulatory body, told the columnist and author of this article that officials with...

Preliminary results of a clinical trial of a new drug for the treatment of coronavirus have shown that its use dramatically reduces the number of patients who require mechanical ventilation, while the time a patient spends in the hospital is reduced by a third, writes the BBC. The treatment developed by the British biotech company Synairgen ...

The United States has purchased nearly the entire global supply of remdesivir, an antiviral drug that could speed up the recovery of coronavirus-infected patients, writes the New York Post. HHS Head Alex Azar announced an agreement to provide large quantities of the drug from Gilead ...

The drug remdesivir to treat COVID-19 will cost $ 3120 for a typical US patient with private insurance, writes Fox Business. Gilead Sciences Inc. published its pricing plans for the drug remdesivir, used to treat COVID-19, saying US hospitals will charge ...

There is a lot of enthusiasm among medical professionals in the US and Europe for an inexpensive drug that appears to be helping to save the lives of people with severe COVID-19. What you need to know about dexamethasone, says The Healthy. When the enthusiasm for hydroxychloroquine diminished due to ...

After the US Food and Drug Administration (FDA) revoked authorization for treatment of coronavirus infection with hydroxychloroquine, the federal government faced the fact that 63 million unused doses remained in government warehouses, writes CNN. The government began to accumulate ...